- Trials with a EudraCT protocol (27)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
27 result(s) found for: Evoked activity.
Displaying page 1 of 2.
EudraCT Number: 2007-003210-33 | Sponsor Protocol Number: ERPME01 | Start Date*: 2007-08-03 | |||||||||||
Sponsor Name:Department of Neurology, Turku University Hospital | |||||||||||||
Full Title: Effect of ropinirole hydrochloride in progressive myoclonic epilepsy of Unverricht–Lundborg type | |||||||||||||
Medical condition: Progressive myoclonus epilepsy of the Unverricht–Lundborg disease (ULD) type | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000908-15 | Sponsor Protocol Number: IMI2-PainCare-BioPain-RCT4 | Start Date*: 2019-09-24 | |||||||||||
Sponsor Name:Aarhus University | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, cross-over trial in healthy subjects to investigate the effects of lacosamide, pregabalin and tapentadol on biomarkers of pain processing observed by... | |||||||||||||
Medical condition: Healthy volunteers (intended indication: pain) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002383-16 | Sponsor Protocol Number: CME-LEM4 | Start Date*: 2016-01-19 |
Sponsor Name:Fundación Investigación Biomédica Hospital Universitario Puerta de Hierro | ||
Full Title: Evaluate the efficacy of the cell therapy with NC1 medication in patients with post-traumatic syringomyelia | ||
Medical condition: Traumatic spinal cord injury, chronically established, associated with syringomyelia and neurological deficit considered irreversible. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-005076-34 | Sponsor Protocol Number: BEL-FMP-12-10325 | Start Date*: 2013-01-03 |
Sponsor Name:Cliniques Universitaires Saint-Luc, Neurologie | ||
Full Title: Prolonged-release oral Fampridine in Multiple Sclerosis: effects on clinical, neurophysiological and quantified gait analysis parameters. A cross-over, double-blinded, placebo-controlled study. | ||
Medical condition: Multiple Sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-000906-52 | Sponsor Protocol Number: SC0806-A101 | Start Date*: 2015-03-24 |
Sponsor Name:BioArctic AB | ||
Full Title: An Open, Randomized, Rehabilitation-controlled Study to Assess Safety, Tolerability, and Efficacy of Heparin Activated Recombinant Human Fibroblast Growth Factor 1 on a Biodegradable Device in Subj... | ||
Medical condition: Complete Traumatic Spinal Cord Injury (TSCI) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) NO (Completed) EE (Prematurely Ended) FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-001541-24 | Sponsor Protocol Number: NeuroIPT-1 | Start Date*: 2016-03-07 |
Sponsor Name:University Medical Center Freiburg | ||
Full Title: Neuroenhancement of Interpersonal Psychotherapy in Major Depression | ||
Medical condition: Major Depression (ICD-10; F32.2/F33.2) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-005282-37 | Sponsor Protocol Number: IDT.LM.LEV.22004-LEMDE | Start Date*: 2005-05-24 |
Sponsor Name:QUIMICA FARMACEUTICA BAYER, S.A. | ||
Full Title: Double-blind, cross-over, placebo-controlled pilot study to characterize the profile of those patients with traumatic spinal cord injury diagnosed by electrophysiological, urodynamic and clinical (... | ||
Medical condition: Erectile dysfunction (ED) | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-012449-48 | Sponsor Protocol Number: ALS-8-09-A-101 | Start Date*: 2009-11-09 |
Sponsor Name:Air Liquide Santé International | ||
Full Title: „Sympathetic neural outflow during Xenon anesthesia in humans“ | ||
Medical condition: We would like to frame the thesis, that a general, inhalative Xenon anesthesia (1 MAC) does not effect the sympathetic outflow and the sympathetic baroreflex reagibility under spontaneous breathing... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-002070-23 | Sponsor Protocol Number: EEGrofl | Start Date*: 2011-10-12 |
Sponsor Name:Maastricht University Medical Center | ||
Full Title: Effects of roflumilast on cognition in healthy adults: a behaviour-EEG study | ||
Medical condition: None; this proof-of-principle study will examine the cognition enhancing effects of roflumilast in healthy subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000641-41 | Sponsor Protocol Number: 2021-000641-41 | Start Date*: 2022-01-07 |
Sponsor Name:Helse Bergen HF, Haukeland University Hospital | ||
Full Title: PROSPECTIVE COMPARISON OF SIROLIMUS AGAINST CORTICOSTEROIDS IN TREATMENT OF PATIENTS WITH ACTIVE THYROID EYE DISEASE | ||
Medical condition: Thyroid Eye Disease (TED) in patients with Graves' Diease. | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: NO (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003618-26 | Sponsor Protocol Number: 215ON203 | Start Date*: 2016-04-18 | |||||||||||
Sponsor Name:Biogen Idec Research Limited | |||||||||||||
Full Title: A Multicenter, Follow-Up Study to Assess Long-Term Electrophysiologic and Clinical Outcomes in Subjects Previously Enrolled in Study 215ON201 | |||||||||||||
Medical condition: Acute Optic Neuritis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) CZ (Completed) ES (Completed) DE (Completed) BE (Completed) SE (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-003937-14 | Sponsor Protocol Number: A-92-52030-164 | Start Date*: 2005-09-27 |
Sponsor Name:IPSEN PHARMA, S.A | ||
Full Title: A phase II, unicentre, randomized, double-blind, parallel and placebo-controlled, pilot study to evaluate the efficacy and safety of Somatuline Autogel (60 mg) in patients with active thyroid-assoc... | ||
Medical condition: Active thyroid-associated ophtalmopathy of moderate intensity. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-005630-21 | Sponsor Protocol Number: RG_06-180 | Start Date*: 2009-04-09 |
Sponsor Name:University of Birmingham
[...]
1. University of Birmingham
2. Birmingham Heartlands Hospital |
||
Full Title: The effect of Pregabalin on Pain progressing in Painful Diabetic Neuropathy | ||
Medical condition: Diabtes and its complications, painful neuropathy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2009-015242-30 | Sponsor Protocol Number: 2009-001 | Start Date*: 2009-11-05 |
Sponsor Name:The Walton Centre for Neurology and Neurosurgery NHS Trust | ||
Full Title: An open study to compare the efficacy of immunoglobulin administered subcutaneoulsy (SCIG) with current best practice in patients with Complex Regional Pain Syndrome (CRPS) | ||
Medical condition: Complex Regional Pain Syndrome (CRPS) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005377-23 | Sponsor Protocol Number: SCI-GHD-201 | Start Date*: 2012-07-18 | ||||||||||||||||
Sponsor Name:Guillem Cuatrecasas Cambra | ||||||||||||||||||
Full Title: A phase II, single-center, prospective, randomized, double-blind, parallel and placebo-controlled pilot clinical study to assess the efficacy and safety of NUTROPIN® in combination with intensive r... | ||||||||||||||||||
Medical condition: Spinal Cord Injury and Growth Hormone Deficiency | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000359-26 | Sponsor Protocol Number: ESTEVE-SANF-201 | Start Date*: 2016-04-29 |
Sponsor Name:Laboratorios del Dr. Esteve, S.A. | ||
Full Title: Phase I/II safety, tolerability and initial efficacy study of adeno-associated viral vector serotype 9 containing human sulfamidase gene after intracerebroventricular administration to patients wit... | ||
Medical condition: Mucopolysaccharidosis type IIIA (Sanfilippo A syndrome) is an inherited lysosomal storage disease caused by a specific lysosomal enzyme deficiency that leads to intracellular accumulation of the ... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004375-12 | Sponsor Protocol Number: TODINELI | Start Date*: 2014-02-13 | |||||||||||||||||||||
Sponsor Name:Center of Mech-Sense | |||||||||||||||||||||||
Full Title: TODINELI Trial A randomized, double-blinded, single-centre, parallel-group, placebo-controlled, prospective trial of the neuroprotective effect of Liraglutide for treatment of diabetic neuropathy | |||||||||||||||||||||||
Medical condition: TODINELI Trial A randomized, double-blinded, single-centre, parallel-group, placebo-controlled, prospective trial of the neuroprotective effect of Liraglutide for treatment of diabetic neuropathy i... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003237-25 | Sponsor Protocol Number: POPPIV4.022.07.16 | Start Date*: 2015-08-21 |
Sponsor Name:University of Oxford | ||
Full Title: A blinded randomised placebo-controlled trial investigating the efficacy of morphine analgesia for procedural pain in infants | ||
Medical condition: Screening for Retinopathy of Prematurity is an essential yet painful routine test that is performed multiple times in infants who are born prematurely. Premature infants also regularly require heel... | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2011-004410-42 | Sponsor Protocol Number: C11-09 | Start Date*: 2012-11-26 | |||||||||||||||||||||
Sponsor Name:Inserm | |||||||||||||||||||||||
Full Title: A phase I/II, open labeled, monocentric study of direct intracranial administration of a replication deficient adeno-associated virus gene transfer vector serotype rh.10 expressing the human ARSA c... | |||||||||||||||||||||||
Medical condition: Early onset forms of MLD | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002699-98 | Sponsor Protocol Number: CB001-OL | Start Date*: 2015-04-14 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: OxLith: Exploration of the short-term physical and psychological effects of lithium in mood instability | |||||||||||||
Medical condition: Bipolar disorder with current mood instability | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
